Black Diamond Therapeutics, Inc. revenue

Black Diamond Therapeutics, Inc.'s revenue was $70.0m in fiscal 2025. Over the last twelve months it was $0.

Revenue history

US$ millions unless shown otherwise. Fiscal years, plus the last twelve months (LTM) when newer.

Black Diamond Therapeutics, Inc.: revenue history, annual
Fiscal year	2018Dec 2018	2019Dec 2019	2020Dec 2020	2024Dec 2024	2025Dec 2025	LTMJun 2026
Revenue	0	0	0	0	70	0

US$ millions unless shown otherwise. Fiscal quarters.

Black Diamond Therapeutics, Inc.: revenue history, quarterly
Quarter	2024 Q3Sept 2024	2024 Q4Dec 2024	2025 Q1Mar 2025	2025 Q2Jun 2025	2025 Q3Sept 2025	2025 Q4Dec 2025	2026 Q1Mar 2026	2026 Q2Jun 2026
Revenue	0	0	70	0	0	0	0	0
Growth on the same quarter a year before	—	—	—	—	—	—	−100.0%	—

Revenue as reported in the company's 10-K and 10-Q filings (for banks, net interest income plus non-interest income). Growth is left blank when the earlier figure was zero or negative.

More: Biotechnology stocks compared, Health Care sector, rankings of US companies

Figures from Black Diamond Therapeutics, Inc.'s SEC filings (10-K and 10-Q), retrieved October 29, 2026. How we read and check them: methodology and data sources. Not investment advice. Back to Black Diamond Therapeutics, Inc.